HC Wainwright restated their buy rating on shares of Sana Biotechnology (NASDAQ:SANA – Free Report) in a research report sent to investors on Thursday morning,Benzinga reports. The firm ...

NEW YORK, NY / ACCESS Newswire / April 17, 2025 / Nevro Corp., recently disclosed that it suffered a data breach that compromised the sensitive personal and protected health data of individuals ...

American Century Companies Inc. boosted its position in shares of Nevro Corp. (NYSE:NVRO – Free Report) by 12.9% during the 4th quarter, according to its most recent 13F filing with the ...

NEW YORK, NY / ACCESS Newswire / April 13, 2025 / Nevro Corp.,recently disclosed that it suffered a data breach that compromised the sensitive personal and protected health data of individuals ...

NEWTOWN, Pa., April 10, 2025 (GLOBE NEWSWIRE) -- Edelson Lechtzin LLP, a national class action law firm, is investigating claims regarding data privacy violations at Nevro Corp. (“Nevro”).

“We are excited to begin the journey of accelerating market penetration of Nevro’s differentiated high-frequency technology and bringing a much-needed treatment option to patients suffering ...

OKLAHOMA CITY, April 03, 2025 (GLOBE NEWSWIRE) -- Nevro Corp. investigated by Federman & Sherwood for data breach. On April 3, 2025, Nevro Corp. filed notice of a data breach with the Attorney ...

REDWOOD CITY, CA – Nevro Corp , a medical device company with annual revenues of $408.52 million and a market capitalization of $221.21 million, announced on Monday that it has completed a merger with ...